Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Eva González‐Barca(Institut Català d'Oncologia), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Silvia Montoto(Queen Mary University of London), Giuseppe Gritti(Ospedale Papa Giovanni XXIII), Joerg Thomas Bittenbring(Saarland University), Didier Blaise(Institut Paoli-Calmettes), John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Andrea Janíková(Masaryk University), Mark Bishton(Nottingham University Hospitals NHS Trust), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Xavier Poiré(Universität Hamburg), Maija Itälä‐Remes(Turku University Hospital), Albert Esquirol(Hospital Universitario Miguel Servet), Jean‐Yves Cahn, Mariagrazia Michieli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Xavier Leleu(Inserm), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Wilfried Schroyens(Antwerp University Hospital), Sonia González de Villambrosía(Marqués de Valdecilla University Hospital), Elisabeth Vandenberghe(Trinity College Dublin), Peter Dreger(Heidelberg University), Johan Maertens(Unknown), Tamás Masszi, Marek Trněný(Charles University), Martina Crysandt(RWTH Aachen University), Esa Jantunen(University of Eastern Finland), Ariane Boumendil(Inserm), H Finel(European Society for Blood and Marrow Transplantation), Zübeyde Nur Özkurt(Gazi University)
Cited by 43
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k